Abstract
Colorectal cancer is one of the most commonly diagnosed and poorly responding to chemotherapy types of cancer, which emphasizes the importance of personalized approach to treatment selection. Short-term primary cell cultures established from patients’ tumors represent a valuable model for testing drug response. In this study, we developed protocols for generation of the short-term primary cell cultures from colorectal cancer tissue and assessment their chemosensitivity using MTT test. Additionally, we showed the possibility of metabolic analysis of patient-derived cancer cells using fluorescence lifetime imaging (FLIM) of autofluorescent cofactor NAD(P)H. Since FLIM of NAD(P)H demonstrates the potential to detect early responses to cancer treatment, we assume that this method, alone or in combination with MTT assay, can be used for choosing the optimal chemotherapy for patients.
© 2019 SPIE/OSA
PDF ArticleMore Like This
Marina V. Shirmanova, Maria M. Lukina, Lyubov’ E. Shimolina, Marina K. Kuimova, Varvara V. Dudenkova, Vladislav I. Shcheslavskiy, and Elena V. Zagaynova
1041102 European Conference on Biomedical Optics (ECBO) 2017
Peter Favreau, Cheri Pasch, Dustin Deming, and Melissa Skala
OmS2D.4 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2017
Rodrigo de Andrade Natal, Vitor Bianchin Pelegati, Caroline Bondarik, Guilherme Rossi Mendonça, Sophie Françoise Derchain, Carmen Passos Lima, Carlos Lenz Cesar, Luís Otávio Sarian, and José Vassallo
95360L European Conference on Biomedical Optics (ECBO) 2015